Brief: Elicera Receives Notice Of Allowance For European Patent
July 11 (Reuters) - Elicera Therapeutics AB ELIC.ST :
* ELICERA THERAPEUTICS RECEIVES NOTICE OF ALLOWANCE FOR
EUROPEAN
PATENT PROTECTING THE ITANK TM PLATFORM
* ONCE GRANTED, PATENT CAN BE KEPT IN FORCE UNTIL 2036
Source text for Eikon: ID:nWkr5cmp2K
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent